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Object. As public concern about the risks of blood transfusions increased in the mid-1990s, avoidance of transfu­
sions became a goal of surgery for sagittal synostosis. This study was performed to confirm a hypothesized reduction 
in transfusion rates in recent years and to identify factors associated with both the need for transfusion and low post­
operative levels of hemoglobin.
Methods. Sagittal synostosis operations performed in children between 1986 and 1999 were reviewed retrospec­
tively. Patients underwent a minimum of vertex strip craniectomy and parietal craniectomies. There were 118 patients 
whose median age at surgery was 4.2 months. The primary end point for analysis was defined as either the receipt of 
a blood transfusion or a postoperative level of hemoglobin less than 70 g/L. Forty-two percent of patients (95% con­
fidence interval [CI] 31-52%) treated before 1996 and 11% of patients (95% CI 0-23%) treated from 1996 onward re­
ceived blood. The reduction in the blood transfusion rate in later years was, in part, related to the acceptance of a lower 
postoperative hemoglobin level, often below 70 g/L. A univariate analysis showed that the only patient or surgical fac­
tors that correlated with reaching the primary end point in a statistically significant manner were the year of surgery 
and the extent of surgery. A logistic regression of the age and weight of the child, length of surgery time (from skin 
opening to skin closure), preoperative hemoglobin level, extent of surgery, and surgeon against the primary end point 
revealed that the best predictor of the need for a blood transfusion or the presence of a postoperative hemoglobin level 
lower than 70 g/L was the extent of surgery (P = 1.4, standard error of the p statistic = 0.44). Once the extent of surgery 
was accounted for in the model, no other covariates significantly improved the model.
Techniques implemented to minimize blood loss since 1995 included the following: use of the Colorado needle for 
scalp incision, selection of the Midas Rex craniotome for cranial cuts, and application of microfibrillar collagen. Post­
operative hemoglobin was allowed to decrease to 60 g/L if the child was stable hemodynamically, before blood was 
administered. There were no cardiovascular, wound healing, or infectious complications, and no surgeries were repeat­
ed for cosmetic reasons.
Conclusions. Low blood transfusion rates were achieved using simple intraoperative techniques and by accepting a 
low level of postoperative hemoglobin.
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N u m e r o u s  surgical procedures are used in the treat­
ment of sagittal synostosis, ranging from simple 
strip craniectomy to total calvarial reconstruction, 
and are associated with different results, complications, and 
utilization of resources.3'6'81013-16'23-25 It is generally recom­
mended that surgery be performed when the infant is youn­
ger than 6 months of age to achieve the best results.2,21,22,24,27 
Whatever the procedure or the patient’s age when surgery 
is performed, significant blood loss is expected, and there 
is the possibility that a blood transfusion will be required 
either intraoperatively or during the early postoperative 
period.
Public understanding of and concern about the risks of 
allogenic blood transfusion have increased during the last 
decade, and avoidance of blood transfusion during surgical 
procedures has become more important. In surgery for sag-
Abbreviation used in this paper: CI = confidence interval.
ittal synostosis a number of methods have been described 
to reduce the need for allogenic blood transfusions. These 
techniques include autologous blood transfusions,17,30 intra­
operative blood salvage,17,30 use of microcautery tips, and 
other elaborate protocols.29-31
In Canada, public concern about the risks of blood trans­
fusion was particularly heightened by the creation in 1993 
of a special commission, headed by Justice Krever, to 
review how 1200 Canadians had been infected with hu­
man immunodeficiency virus through tainted blood given 
to them in the early 1980s. The Krever Commission held 
public hearings on this matter for many years and finally is­
sued a report in November 1997.5 During this time period 
(the mid-1990s), neurosurgeons at British Columbia’s Chil­
dren’s Hospital, Vancouver, Canada, were influenced by the 
public’s concerns and felt some pressure to minimize the 
use of perioperative allogenic blood transfusions. This was 
particularly true for operations performed for craniosyn- 
ostosis, for which the indications for surgery are primarily
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cosmetic. By the mid-1990s avoidance of allogenic blood 
transfusion in children undergoing surgery for craniosynos- 
tosis became one goal of surgery for all three pediatric neu­
rosurgeons at this hospital.
It was our expectation and the hypothesis for this study 
that the amount of blood lost during surgery for sagittal syn­
ostosis and the rate of allogenic blood transfusions declined 
in the latter half of the 1990s, compared with earlier years. 
The purpose of this study was to confirm that transfusion 
rates decreased during that time period, to describe tech­
niques used to limit intraoperative blood loss and avoid 
transfusions, and to determine if any factors, such as patient 
age and weight at surgery or extent of the surgical proce­
dure, correlated with the transfusion rate or a low level of 
postoperative hemoglobin.
Clinical Material and Methods
Patient Population
A retrospective chart review was performed for patients 
who underwent surgery for sagittal synostosis between Jan­
uary 1986 and December 1999. Information regarding op­
erative details, hemoglobin levels, perioperative blood loss, 
blood transfusions, and the cephalic index at presentation 
and at the latest follow-up examination was obtained. The 
cephalic index was the ratio between the maximum bipa- 
rietal or bitemporal diameter and the maximum anteropos­
terior diameter.
One hundred eighteen patients were included in this 
study; the median age of these patients was 4.2 months. 
Two thirds of the patients were younger than 6 months of 
age at operation, whereas approximately 10% were older 
than 1 year of age.
Operative Procedure
Preoperatively, the hemoglobin level was measured in 
all patients. One unit of packed red blood cells, either regu­
lar blood-bank blood or donor-directed blood, was cross­
matched in case it should be required perioperatively. The 
patients were admitted on the day before surgery in the ear­
ly part of the study and on the day of surgery since 1995. 
Apart from three patients with iron deficiency anemia in 
whom the hemoglobin level was less than 100 g/L, who 
were treated with iron for 1 month, no patient received any 
treatment, such as erythropoietin, to optimize hemoglobin 
levels prior to surgery. No patient underwent harvesting of 
autologous blood.
The surgical procedures performed in patients younger 
than 1 year of age were fairly homogeneous during this 
time period and are detailed later in this paper. The tech­
niques for children older than 1 year of age were quite 
variable. The anesthesiologist assigned to each case was 
variably selected from a group of nine pediatric anesthesi­
ologists, and may or may not have had a special interest in 
neurosurgical procedures. Each operation was performed 
by one of three surgeons (P.S., D.D.C., and J.K.), who was 
usually aided by a resident assistant.
The scalp was infiltrated with a mixture of adrenaline and 
xylocaine. A bicoronal scalp incision was made. Before 
1995, the incision was made using a scalpel and hemostat­
ic clips were applied to the scalp. From 1995 onward, cut­
ting needle cautery (Colorado tip; Colorado Biomedical, 
Evergreen, CO) was used with increasing frequency for the 
skin incisions, negating the need in some cases for he­
mostatic clips. Anterior and posterior subgaleal flaps were 
turned using the unipolar cautery to expose the entire cra­
nial vertex from the coronal sutures to the inion. Bipolar 
coagulation of blood vessels, placement of microfibrillar 
collagen on the subgaleal surface of the scalp flaps, and 
application of bone wax to the cut edges of bone aided in 
hemostasis. All patients underwent a standard wide mid­
line sagittal craniectomy measuring 4 to 6 cm, and parietal 
craniectomies to allow the parietal bones to move lateral­
ly readily. Depending on the shape of the cranium, anteri­
or and/or posterior parietal wedge craniectomies were often 
performed to remove the most narrowed areas. In addition, 
barrel stave or other parietal osteotomies were usually per­
formed. If there was significant frontal bossing or occipital 
protrusion, frontal or occipital craniotomies and remodeling 
procedures were sometimes performed to correct these de­
fects. These additional procedures were performed more 
frequently during the first half of the series. For the purpose 
of analysis, the extent of surgery was subdivided into three 
categories: “basic,” in which only vertex and parietal cra­
niectomies were done; “moderate,” in which either an oc­
cipital craniectomy or frontal remodeling was added; and 
“extensive,” in which both occipital and frontal remodeling 
were performed. All bone cutting was performed with the 
aid of the Midas Rex craniotome (Medtronic Midas Rex, 
Fort Worth, TX). From 1996 onward, one of the surgeons 
indicated to families preoperatively that a planned frontal or 
occipital remodeling might be aborted if the child was be­
lieved to be approaching the need for blood transfusion and 
the remainder of the procedure had been completed.
Blood Products
The estimated blood loss was determined on the basis of 
the surgeon’s and/or anesthesiologist’s best estimate at the 
time of the procedure, as documented in the hospital record. 
Estimated blood volume was calculated on the basis of 
80 ml/kg body weight.20,29 Calculated blood loss, or CBL, 
was derived from the formula [CBL = EBV Ln(Hbpre/ 
Hbpost) volume transfused], where EBV represents esti­
mated blood volume; Ln, logarithm (natural form); Hbpre, 
preoperative hemoglobin; and Hbpost, postoperative hemo- 
globin.32
Statistical Analysis
One end point was chosen for statistical analysis. As part 
of this study, we wished to examine factors related to the 
surgery that might have been associated with sufficient loss 
of blood to precipitate a blood transfusion. Because indica­
tions for blood transfusion could have varied among the dif­
ferent anesthesiologists and surgeons, it was believed that a 
better end point than blood transfusion would be a low he­
moglobin level postoperatively. We chose a level of 70 g/L 
as the end point level; this is a level below the point at 
which many physicians would consider giving blood. We 
recognized that, in children who received a blood transfu­
sion intraoperatively, the postoperative hemoglobin level 
would probably never drop to less than 70 g/L, even though 
an end point had clearly been reached, because enough 
blood had been lost to require a transfusion. We therefore
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TABLE 1
Descriptive statistics by year of operation
Fig . 1. Bar graph show ing the percentages o f  patients w h o  re­
ce ived  transfusions and the percentage w ith a hem oglobin  (H b) le v ­
e l low er than 7 0  g /L  from  1986 to 1999.
decided that the primary end point should be either a trans­
fusion of blood products or a postoperative hemoglobin 
level below 70 g/L, even if no blood was transfused.
The rate of blood transfusion was plotted by 2-year pe­
riods. Confidence intervals for the proportions were cal­
culated using normal approximation. The chi-square test, 
the Fisher exact test, a t-test, and the Wilcoxon test were 
used to investigate differences between those patients who 
reached the primary end point and those who did not in 
terms of year of operation, extent of surgery, surgeon, 
weight of the child, duration of surgery (time from skin op­
ening to skin closure), and preoperative hemoglobin level. 
All covariates, except the year in which surgery was per­
formed, were also included in a logistic regression to ex­
plore the potential interrelationships between the surgical 
and patient-related factors and the primary end point. To 
control for multiple testing, we used a Bonferroni-corrected 
Type I error rate (p value) of 0.01. Analyses were conduct­
ed using commercially available statistical computer soft­
ware (SPSS version 7.5; SPSS Inc., Chicago, IL).
Results
Transfusion Requirements
Forty-one (34.7%) of 118 patients in the study received 
blood transfusions. A decreased rate of blood transfusion 
was evident in later years, particularly from 1996 onward 
(Fig. 1). The percentage of patients with a postoperative he­
moglobin level lower than 70 g/L increased from the start 
of the study to 1995 and then decreased thereafter (Fig. 1). 
Among the patients who received a blood transfusion, 26 
(68%) of 38 patients who did so before 1996 and two (67%) 
of three patients who did so since 1996 received transfu­
sions, even though their hemoglobin levels had not dropped 
below 70 g/L and there were no signs of hemodynamic in­
stability. Among those patients with seemingly adequate 
hemoglobin levels, 24 (92%) of the 26 patients who re­
ceived blood transfusions before 1996 and two (100%) of 
two patients who received blood later did so intraoperative- 
ly, presumably because the anesthesiologist or surgeon was
1986-1995 1996-1999
Variable Group 1 Group 2
age (mos)* 4.1 (1.9-38.6) 4.8 (2.2-81.3)
weight (kg)* 7.1 (4.8-16.1) 7.1 (5-22)
preop hemoglobin (g/L)* 113 (93-136) 116 (80-139)
duration of op (mins)t 78 (44-235) 135 (90-270)
extent of surgeryt
basic 19 (21) 20 (74)
moderate 62 (68) 6 (22)
extensive 10 (11) 1 (4)
surgeont
A 37 (41) 15 (56)
B 43 (47) 9 (33)
C 11 (12) 3 (11)
* Values are expressed as the median (range). 
t  Duration of operation from skin opening to skin closure (range). 
t  Values are expressed as number of patients (percentage).
concerned about the extent of blood loss. The other two pa­
tients in the first group received transfusions because their 
postoperative hemoglobin levels were believed to be unac- 
ceptably low, although not below 70 g/L.
Based on the results of the transfusion rates, and in keep­
ing with the original hypothesis of the study, patients in­
to two groups for analysis. Group 1 included patients who 
underwent surgery between January 1986 and December 
1995, whereas Group 2 included patients who underwent 
operative intervention between January 1996 and Decem­
ber 1999. The demographic characteristics of the patients in 
the two groups were similar (Table 1); however, patients in 
Group 2 tended to have undergone less extensive surgery, 
albeit with longer operative times, than patients in Group 1.
Blood transfusions were given to 38 (41.8%) of 91 pa­
tients in Group 1 (95% CI 31-52%) and three (11.1%) of 27 
patients in Group 2 (95% CI 0-23%; Table 2). The average 
amount of estimated blood volume transfused was lower in 
patients in Group 2 (2.6% compared with 10.9% in Group
1). The absolute lowest hemoglobin recorded was 50 g/L 
in a patient who did not receive a blood transfusion, where­
as the average lowest postoperative hemoglobin level was 
87 g/L overall, with similar values over both study peri­
ods. The estimated blood loss and calculated blood loss­
es were similar throughout the study. The estimated blood 
loss underestimated the calculated blood loss by more than 
100% (note that the formula used in this study only partial­
ly accounts for hemodilution in a standardized fashion) 
(Fig. 2).
The indications for transfusion were determined on the 
basis of individual patients, surgeons, and anesthesiologists. 
In general, patients received transfusions intraoperatively 
if the surgeon or anesthesiologist was concerned about the 
extent of blood loss or if the child was hemodynamical- 
ly unstable. During the postoperative period, patients re­
ceived transfusions either because the hemoglobin level 
was believed to be too low or there were signs of hypo­
volemia, such as tachycardia, hypotension, and tachypnea. 
The percentage of patients in whom the postoperative he­
moglobin level reached less than 70 g/L was lower in 
Group 2 (Table 2 and Fig. 1), but the percentage of patients 
in whom the hemoglobin level reached less than 80 g/L was
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Fig. 2. H istogram  show ing the percentages o f  patients w ho re­
ce ived  transfusions, the am ount o f  b lood  transfused, the estim ated  
blood  lo ss  (est), and the calculated b lood  lo ss  (calc) for patients w ho  
underwent surgery betw een 1986 and 1995 (black bars) and be­
tw een 1996 and 1999 (gray bars). The am ount o f  b lood  transfused, 
estim ated b lood  lo ss , and calculated b lood  lo ss , are expressed  as a 
percentage o f  the patient’s estim ated b lood  volum e. The am ount o f  
blood  transfused w as low er after 1995, despite sim ilar estim ated  
and calculated b lood  losses.
the same in the two groups. There were no adverse reac­
tions to the blood transfusion. There were no cardiovascu­
lar, wound healing, or infectious complications.
For the purposes of further analysis, as explained in 
Clinical Material and Methods, the primary end point was
TABLE 2 
Blood loss and transfusion results*
Parameter Group 1 Group 2 Overall
% of patients who received 41.8 11.1 34.7
transfusion
EBL (ml)
mean 74 65 72
range 10-300 25-300 10-300
CBL (ml)
mean 220 197 215
range 9-826 42-369 9-826
EBV (ml)
mean 603 635 610
range 384—1288 400-1760 384-1760
EBL/CBL (%)
mean 44 33 42
range 5-448 12-98 5-448
EBL as % of total
mean 12 9 12
range 2-50 4-32 2-50
CBL as % of total
mean 37 32 35
range 2-108 8-66 2-108
lowest hemoglobin (g/L)
mean 88 85 87
range 51-142 50-145 50-145
% of patients w / postop 23.1 11.1 20.3
hemoglobin 70 g/L
% of patients w / postop 37.4 37.0 37.3
hemoglobin 80 g/L
BV transfused (ml)
mean 10.8 2.6 8.2
range 0-65.2 0-30.9 0-64.8
* Group 1 includes patients treated before 1996 and Group 2 those treated 
from 1996 onward. Abbreviations: BV = blood volume; CBL = calculated 
blood loss; EBL = estimated blood loss; EBV = estimated BV.
F ig . 3. B ar graph dem onstrating percentages o f  patients w ho  
reached the primary end point from  1986 to 1999. T he primary end  
point w as defined  as either receiv ing a b lood  transfusion or having  
a postoperative hem oglobin  lev e l low er than 7 0  g/L.
reached when a patient received a transfusion of blood 
products or when the postoperative hemoglobin level was 
below 70 g/L, even if no blood was transfused. The rate at 
which patients attained the primary end point fluctuated be­
tween 35% and 75% from 1986 to 1995, but decreased to 
less than 20% after 1995 (Fig. 3). The relationship between 
individual patient and surgical factors and the attainment of 
the primary end point of the study was examined using uni­
variate analyses (Tables 3 and 4). The only factors that cor­
related with the primary end point in a statistically signif­
icant manner were year of surgery and extent of surgery. 
A multivariate analysis was performed using regression 
to explore the potential interrelationships of different vari- 
ables—the age and weight of the child, duration of surgery 
(time from opening the skin to closing the skin), preopera­
tive level of hemoglobin, extent of surgery, and surgeon— 
with reaching the primary end point. Logistic regression 
revealed that, for the present data, the best predictor of a 
postoperative hemoglobin level lower than 70 g/L or re­
ceiving a blood transfusion (that is, reaching the primary 
end point) was extent of surgery O  = 1.4, standard error of 
the (§ statistic = 0.44). The odds of reaching the primary end 
point for extensive surgery over basic surgery was 3.98 
(95 % CI 1.67-9.5). Once the extent of surgery was account­
ed for in the model, no other covariates significantly im­
proved the model.
Cosmetic Outcome. At an average follow-up period of 
26.1 months, the mean increase in the cephalic index com­
pared with that measured preoperatively was 9.9% (Table 
5). Similar values for pre- and postoperative cephalic in­
dices were obtained in Groups 1 and 2. In three patients 
there was a decrease (worsening) in the cephalic index 
postoperatively. In two of these patients the indices had 
been significantly improved in the early postoperative pe­
riod and gradually drifted toward a more scaphocephalic 
ratio over a mean of 4.3 years of follow-up observation, 
ending up with a lower cephalic index than preoperative- 
ly. Both patients were noted to have good cosmetic results, 
despite the worsened cephalic index. In the third patient 
the preoperative ratio was 0.78 and the postoperative ratio 
was 0.77 1 year after surgery, despite the fact that there
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TABLE 3
Results o f  univariate analysis o f  continuous variables
Primary End Point*
Variable Attained Not Attained Statistic
p
Value
age (mos) 4.3 (1.9-81.3) 4.1 (2.1-28.9) W = 3875.5 0.78
weight (kg) 7.2 (4.8-22.0) 6.8 (5.1-14.5) W = 3006.0 0.63
duration of op (mins)t 92 (44-270) 90 (50-235) tH6 = 0.59 0.56
preop hemoglobin 115 (94-139) 112 (80-136) t116 = 1.84 0.07
* Values are expressed as median (range). The end point was attained in 
66 patients; it was not attained in 52. 
t  Time was log transformed for statistical testing.
was much cosmetic improvement. Only one patient un­
derwent a repeated operative procedure. This child ex­
perienced elevated intracranial pressure and underwent a 
cranial expansion procedure 4.4 years after the original 
surgery. In two additional patients the cosmetic results 
were believed to be unsatisfactory by the surgeon. One of 
these patients suffered from fetal alcohol syndrome and 
the associated microcephaly was believed to be the major 
factor responsible for the poor result. In the other patient, 
a repeated operation was recommended, but the patient’s 
parents did not believe the cosmetic issue warranted re­
peated operation. Since 1996, a planned occipital-frontal 
remodeling was aborted to avoid transfusion in only one 
patient. In that patient, the results of the surgery were 




A variety of surgical procedures have been described for 
the treatment of sagittal synostosis. Some authors have rec­
ommended a relatively simple technique such as strip cra­
niectomy, relying, in part, on brain growth to remodel the 
skull shape.101325 Others have recommended a more com­
plicated procedure aimed at the immediate correction of 
skull contour.1114 24 Endoscopic techniques have also been 
described more recently.16
The cosmetic outcomes of these various procedures have 
been compared.261418'21'26 The procedures used in the pa­
tients described in this study are variations of an extended 
strip craniectomy. Authors of previous reports have sug­
gested that more extensive procedures (such as subtotal cal- 
variectomy and remodeling) may produce head shapes with 
a more normal cephalic index than those achieved using ex­
tended strip craniectomies.2,718,21,26 If the goal of surgery is to 
produce a normal cephalic index and one is not concerned 
about the need for a blood transfusion or other risks associ­
ated with the more extensive surgery, the more extensive 
procedure may be preferable. It is our opinion, however, 
that the goal should not necessarily be a normal cephalic 
index, but simply an improvement in the shape of the cra­
nium, such that the child’s appearance is considered “nor­
mal” by members of society and, in particular, the child’s 
peers. Furthermore, we believe that one must balance the 
goal of this essentially cosmetic surgery with the operative 
risks, including the potential risks of allogenic blood trans-
TABLE 4






Primary End Point (%) X2
p
Value
yrs of study 9.3 0.002
1986-1995 91 47 (52)
1996-1999 27 5 (19)
extent NA* 0.001
basic 39 9 (23)
moderate 68 34 (50)
extensive 11 9 (82)
surgeon 4.5 0.11
A 52 25 (48)
B 52 18 (35)
C 14 9 (64)
* The Fisher exact test was used. Abbreviation: NA = not applicable.
fusion. The average postoperative cephalic index report­
ed here is consistent with those reported by other authors 
who perform extended strip craniectomies.7,18,21,26 With hair 
growth and further skeletal development, the appearance of 
someone with a postoperative cephalic index in the range 
achieved in this group of patients would usually allow the 
child to pass for what is deemed normal. The assessment of 
cosmetic results after surgery for sagittal synostosis is sub­
jective, but the fact that no patient underwent a repeated op­
erative procedure for cosmetic reasons attests to the claim 
that the results were, at least, acceptable.
It is difficult to argue against more extensive procedures 
based on the complication rate alone, because the perioper­
ative complication rate, even for much more radical crani­
ectomies and calvarial remodeling, is low.1,2,11,15,19 The op­
erative times and hospital stays, when reported, are quite 
similar among the various procedures, with stays generally 
ranging from 3 to 5 days and operative times from 1 to 2 
hours.1,10,11,25 Only procedures in children older than 1 year 
of age are consistently longer.14 A significant difference 
noted among procedures, especially for the series reported 




Parameter Group 1 Group 2 Overall
preop cephalic index
mean 0.67 0.69 0.67
range 0.58 to 0.77 0.63 to 0.78 0.58 to 0.78
postop cephalic index
mean 0.74 0.74 0.74
range 0.65 to 0.84 0.66 to 0.86 0.65 to 0.86
% correction
mean 10.5 7.9 9.9
range - 1 .5  to 35.5 1.5 to 25.6 1.5 to 35.5
follow up (mos)
mean 30.6 11.0 26.1
range 0.1 to 41.3 0.1 to 41.3 0.1 to 112.3
hospital stay (days)
mean 3.9 3.0 3.7
range 2 to 8 2 to 4 2 to 8
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Many authors have reported transfusion rates of nearly 
100% for sagittal synostosis surgery1,3,9,11,27 and most others 
have reported rates significantly higher than 50%.10,19 The 
known risks of blood transfusion include hemolytic reac­
tions, graft versus host disease, allergic reactions, electro­
lyte abnormalities, and the more publicly realized risks 
of hepatitis and human immunodeficiency virus.173033 The 
risks of transfusion can be acutely life threatening,4 or may 
not be realized until years later.5 In the setting of surgical 
correction for sagittal synostosis, which is almost entirely 
a cosmetic matter, and in light of public concern in Cana­
da about the safety of blood, our position is that the risk of 
long-term morbidity can be decreased by minimizing the 
use of blood products perioperatively.
Over the course of the 14 years covered by this study, the 
rate of blood transfusion at our institution has gradually de­
creased from greater than 50% before 1991 (the initial years 
of the study) to 11% after 1995 (the most recent years of the 
study). The rate at which the primary end point was reached 
fluctuated between 35 and 75% from 1986 to 1995, but de­
creased to less than 20% after 1995. In the early years of the 
study (1986-1991), during which more than 50% of pa­
tients received transfusions, very few patients were found to 
have postoperative hemoglobin levels below 70 g/L (Fig. 1) 
and 74% of the transfusions occurred intraoperatively. This 
most likely reflected the common practice of transfusing 
blood once blood loss had begun, in an attempt to keep 
ahead of the expected blood loss, as well as the unwilling­
ness to allow the postoperative hemoglobin level to fall be­
low 70 g/L before initiating transfusion. In the middle years 
of the study (1992-1995), the rate of blood transfusion de­
creased to between 20 and 30%, and this was associated 
with a 40% rise in the percentage of patients in whom the 
postoperative level of hemoglobin was less than 70 g/L. 
There was no change in the percentage of patients who 
reached the primary end point (Fig. 3). The percentage of 
transfusions started intraoperatively decreased from 74% 
before 1992 to 50% during the years 1992 to 1995. These 
results suggest that the reduction in the transfusion rate in 
the middle years of the study may have occurred almost 
completely because of the willingness to accept a lower 
postoperative hemoglobin level and, specifically, to allow 
the hemoglobin level to fall below 70 g/L without trans­
fusing blood. In the last 4 years of the study (1996-1999), 
the rate at which the primary end point was reached was re­
duced to less than 20% and the transfusion rate was 11%. 
The estimated and calculated blood loss also decreased. The 
fact that the calculated blood loss was on average twice that 
estimated at the time of operation has caused us to examine 
and reevaluate our estimations of intraoperative blood loss. 
The findings suggest that these most recent low transfusion 
rates were achieved not only by a willingness to accept a 
low hemoglobin level postoperatively, but also by imple­
menting effective surgical techniques to limit intraoperative 
and perioperative blood loss. Based on the findings of the 
multivariate analysis, the most important factor in limit­
ing blood loss was the trend toward a less extensive surgi­
cal procedure. In all cases a minimum of a vertex craniec­
tomy and multiple parietal osteotomies were performed, but 
frontal remodeling, occipital craniectomy, or both were not 
performed as frequently after 1995. Indeed, one of the sur­
Transfusion Practices geons was prepared to terminate the procedure after the ver­
tex and parietal craniectomies, if proceeding with a planned 
occipital or frontal remodeling would necessitate a blood 
transfusion. This occurred in only one patient.
Other surgical techniques, which could not be examined 
in this study, may have played a role in limiting blood loss. 
These included the use of the Colorado needle for the skin 
incision, application of microfibrillar collagen to the subga- 
leal flaps, and, perhaps, a more meticulous approach to ob­
taining rapid hemostasis. It is noteworthy, in this regard, 
that the length of surgery after 1995 was more prolonged, 
despite the trend toward less extensive surgery, and this 
may reflect a more meticulous approach to the surgery and 
hemostasis. Despite the increased operative times, there 
were no infections in this series.
The patient’s age, weight, length of surgery, preoperative 
hemoglobin level, and surgeon did not have a statistically 
significant effect on the rate at which the primary end point 
was attained, according to either the univariate or multivar­
iate analysis.
To avoid allogenic blood transfusions, complicated pro­
tocols have been devised, consisting of preoperative au­
tologous donation, hemodilution, and intraoperative and 
postoperative blood salvage.30 We have developed a much 
simpler approach that requires significantly less resource 
utilization. By meticulous attention to the prevention of in­
traoperative blood loss and by avoiding more complicated 
procedures than necessary to obtain a satisfactory cosmetic 
outcome, it has been possible to reduce the amount of blood 
loss. Nonetheless, one of the most critical aspects of avoid­
ing blood transfusions has been a willingness to accept a 
lower postoperative hemoglobin level than that which is 
usually recommended. We are prepared to allow the lev­
el of hemoglobin to decrease as low as 60 g/L, as long as 
the patient’s cardiovascular parameters are stable. It used to 
be said that a hemoglobin of 100 g/L was the lowest ac­
ceptable level during the postoperative period, because of 
concerns about cardiovascular and wound healing compli­
cations. Nevertheless, it is likely that such complications 
occur at much lower levels of hemoglobin than 100 g/L,28 
and indeed, in this series there were no such complications 
and no infections, even in patients in whom the hemoglobin 
level was lower than 70 g/L. Limiting the use of transfu­
sions and acceptance of lower hemoglobin levels has been 
studied in other populations of patients and has actually 
been shown in some cases to reduce incidences of morbid­
ity and mortality significantly.12
Conclusions
We have described an approach to the surgical manage­
ment of sagittal synostosis in infants that involves extended 
strip craniectomy; this approach has been modified first to 
obtain acceptable cosmetic results and second to limit the 
use of blood products during the perioperative period. Ac­
ceptable cosmetic results and low blood transfusion rates 
can be achieved using simple techniques to minimize in­
traoperative blood loss and operative complexity, and by 
accepting a low level of postoperative hemoglobin. For 
children, who have many years of life ahead of them, the 
avoidance of even potential long-term morbidity is ex­
tremely important.
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